Pardubice, Czechia

Zdenek Krcil

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Zdenek Krcil: Innovator in Neuromodulation Technology

Introduction

Zdenek Krcil is a prominent inventor based in Pardubice, Czech Republic. He has made significant contributions to the field of neuromodulation, holding a total of 5 patents. His work focuses on developing innovative medical devices aimed at improving patient care through advanced technology.

Latest Patents

Krcil's latest patents include a "Selective Neuromodulation Apparatus" and a "Neuromodulation Medical Treatment Device." The selective neuromodulation apparatus features multiple active electrodes that are electrically isolated and arranged in an electrode array. This device is designed to transmit electric pulses selectively to each active electrode, allowing for precise neuromodulation. The neuromodulation medical treatment device is aimed at stimulating peripheral nerves and includes a pulse generator connected to at least one active electrode. This electrode is designed to be attached to a patient's skin near peripheral nerve branches, enabling effective stimulation through generated electrical pulses.

Career Highlights

Throughout his career, Zdenek Krcil has worked with notable companies such as Stimvia S.r.o. and Tesla Medical s.r.o. His experience in these organizations has contributed to his expertise in developing cutting-edge medical technologies.

Collaborations

Krcil has collaborated with talented individuals in his field, including Lukas Doskocil and Michal Drahos. These partnerships have fostered innovation and advancement in neuromodulation technologies.

Conclusion

Zdenek Krcil's contributions to neuromodulation technology highlight his role as a leading inventor in the medical field. His innovative patents and collaborations continue to pave the way for advancements in patient treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…